Compare ECOR & CMTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ECOR | CMTL |
|---|---|---|
| Founded | 2005 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Radio And Television Broadcasting And Communications Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.6M | 64.4M |
| IPO Year | 2018 | N/A |
| Metric | ECOR | CMTL |
|---|---|---|
| Price | $4.83 | $3.19 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $25.50 | $6.00 |
| AVG Volume (30 Days) | 32.4K | ★ 186.7K |
| Earning Date | 11-05-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $29,835,000.00 | ★ $494,760,000.00 |
| Revenue This Year | $28.61 | N/A |
| Revenue Next Year | $41.21 | $5.15 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 27.90 | N/A |
| 52 Week Low | $4.16 | $1.19 |
| 52 Week High | $19.49 | $4.88 |
| Indicator | ECOR | CMTL |
|---|---|---|
| Relative Strength Index (RSI) | 43.14 | 46.44 |
| Support Level | $4.78 | $3.17 |
| Resistance Level | $5.09 | $3.73 |
| Average True Range (ATR) | 0.21 | 0.23 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 4.88 | 25.56 |
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
Comtech Telecommunications Corp is a provider of modern communications solution incorporated in USA. The company is engaged in designing, developing, producing and marketing products, systems, and services for communications solutions. It is engaged in two business segments, Satellite and Space Communications and Terrestrial and Wireless Networks. It's Space and satellite is USA based providers of modems and high-power amplifiers, a market leader in troposcatter technologies, and serves some of the world's defense contractors and allied foreign governments. Terrestrial and Wireless Networks segment is a provider of next generation 911 infrastructure and solutions for state and local governments and carriers. Majority of sales are generated from Satellite and Space Communications segment.